Diabetic Shoes For Women Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Brooks is the best-performing diabetic shoes for women brand in July 2026, moving 1,300 units across 3 ASINs for 23.2% of Top 10 volume. Scurtain follows with 1,200 units (21.4%), ahead of CIRZUEX on 1,000 units (17.9%).

With 7 brands splitting the Top 10 and 62.5% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $14.99 to $119.80, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, one ASIN forced its way in: B0DDFHHKTQ booked 400 units at $109.95. On the growth side, B0DHJMQMJL leads positive momentum with ▲ 100.0% MoM growth on 200 units, with B0FHB8WKRW close behind at ▲ 100.0% MoM on 100 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.